Marika Vezzoli

Dr. Marika Vezzoli

University of Brescia, Brescia, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2013 in Oxford Bulletin of Economics and Statistics
Verified
Journal Article
Closed access
PDF file
Roberto SavonaRoberto Savona
Roberto Savona
MVMarika Vezzoli
Marika Vezzoli

1 June 2015 in Laboratory Investigation
Verified
Journal Article
Closed access
FFFiorella Faggi
Fiorella Faggi
Nicola ChiarelliNicola Chiarelli
Nicola Chiarelli
Marina ColombiMarina Colombi
Marina Colombi
SMStefania Mitola
Stefania Mitola
RRRoberto Ronca
Roberto Ronca
AFAlessandro Fanzani
Alessandro Fanzani

19 March 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
AMAlessandra Minelli
Alessandra Minelli
RSRosana Carvalho Silva
Rosana Carvalho Silva
Stefano BarlatiStefano Barlati
Stefano Barlati
MVMarika Vezzoli
Marika Vezzoli
SCSara Carletto
Sara Carletto
AVAntonio Vita
Antonio Vita
Despite extensive research on COVID-19’s impact on healthcare workers, few studies have targeted mental health workers (MHWs) and none have investigated previous traumatic events. We investigated psychological distress in MHWs after the first lockdown in Italy to understand which COVID-19, sociodemographic, and professional variables represented greater effects, and the role of previous trauma. The survey included sociodemographic and professional questions, COVID-19 variables, and the questionnaires Life Events Checklist for DSM-5 (LEC-5), Impact of Event Scale—Revised (IES-R), and Depression Anxiety Stress Scales 21 (DASS-21). On the 271 MHWs who completed the survey (73.1% female; mean age 45.37), we obtained significant effects for contagion fear, experience of patients’ death, increased workload, and worse team relationship during the first wave. Nurses were more affected and showed more post-traumatic stress symptoms, assessed by IES-R, and more depressive, anxiety, and stress symptoms, assessed by DASS-21. The strongest risk factors for distress were greater age, professional role, increased workload, worse team relationship, and separation from family members. Previous experience of severe human suffering and unwanted sexual experiences negatively impacted IES-R and DASS-21 scores. Being a psychiatrist or psychologist/psychotherapist and good team relationships were protective factors. Recent but also previous severe stressful events might represent relevant risk factors for distress, reducing resilience skills. Identifying vulnerable factors and professional categories may help in the development of dedicated measures to prevent emotional burden and support psychological health. Highlights: Psychological distress in mental health workers in the COVID-19 pandemic is more frequent in nurses, who experience more depression, anxiety, and post-traumatic stress symptoms. Previous and recent stressful events are risk factors for distress and should guide intervention strategies.

19 December 2017 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
IGInflammation in HIV Study Group
Inflammation in HIV Study Group
EReugenia quiros roldan
eugenia quiros roldan
Francesco CastelliFrancesco Castelli
Francesco Castelli
PLPaola Lanza
Paola Lanza
CPChiara Pezzoli
Chiara Pezzoli
IZIsabella Zanella
Isabella Zanella
Anemia is frequent during HIV infection and is predictive of mortality. Although cART has demonstrated to reduce its prevalence, several patients still experience unresolved anemia. We aimed to characterize iron homeostasis and inflammation in HIV-infected individuals with mild anemia in relation to cART. In this retrospective cohort study, HIV-infected patients with mild anemia, CD4+ cells > 200/mm3 at baseline, maintaining virological response for 12 months after cART starting were selected within the Standardized Management of Antiretroviral Therapy Cohort (MASTER) cohort. Several inflammation and immune activation markers and iron homeostasis indexes were measured in stored samples, obtained at cART initiation (T0) and 12 months later (T1). Patients were grouped on the basis of hemoglobin values at T1: group A (> 13 g/dl) and B (< 13 g/dl). Wilcoxon rank sum test was used to compare biomarker values. Pearson correlation coefficients were calculated for all variables. cART improved CD4+ and CD8+ cell counts and their ratio, but this effect was significant only in group A. Only these patients had mild iron deficiency at T0 and showed higher transferrin and lower percentage of transferrin saturation than patients of group B, but differences disappeared with cART. cART decreased inflammation in all patients, but group B had higher levels of all markers than group A, reaching statistical significance only for IL-8 values at T1 (16 vs 2.9 pg/ml; p = 0.017). Hepcidin and IL-6 levels did not show significant differences between groups. Hemoglobin levels both at T0 and T1 did not correlate with any marker. Baseline mild anemia in HIV-infected patients cannot always be resolved with durable efficient cART, possibly due to residual inflammation or immune activation rather than unbalanced iron homeostasis. Further research is needed on cytokine profiling to understand the mechanisms that induce anemia in HIV with suppressive cART.

26 December 2020 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
GAGIULIA ABATE
GIULIA ABATE
MVMarika Vezzoli
Marika Vezzoli
LPLetizia Polito
Letizia Polito
AGAntonio Guaita
Antonio Guaita
DADiego Albani
Diego Albani
Daniela UbertiDaniela Uberti
Daniela Uberti
Early diagnosis of Alzheimer’s disease (AD) is a crucial starting point in disease management. Blood-based biomarkers could represent a considerable advantage in providing AD-risk information in primary care settings. Here, we report new data for a relatively unknown blood-based biomarker that holds promise for AD diagnosis. We evaluate a p53-misfolding conformation recognized by the antibody 2D3A8, also named Unfolded p53 (U-p532D3A8+), in 375 plasma samples derived from InveCe.Ab and PharmaCog/E-ADNI longitudinal studies. A machine learning approach is used to combine U-p532D3A8+ plasma levels with Mini-Mental State Examination (MMSE) and apolipoprotein E epsilon-4 (APOEε4) and is able to predict AD likelihood risk in InveCe.Ab with an overall 86.67% agreement with clinical diagnosis. These algorithms also accurately classify (AUC = 0.92) Aβ+—amnestic Mild Cognitive Impairment (aMCI) patients who will develop AD in PharmaCog/E-ADNI, where subjects were stratified according to Cerebrospinal fluid (CSF) AD markers (Aβ42 and p-Tau). Results support U-p532D3A8+ plasma level as a promising additional candidate blood-based biomarker for AD.

14 January 2022 in Molecular Therapy
Verified
Journal Article
Open access
GFGaia Faustini
Gaia Faustini
FLFrancesca Longhena
Francesca Longhena
AMAnna Masato
Anna Masato
VBValentina Bassareo
Valentina Bassareo
RFRoberto Frau
Roberto Frau
Arianna BellucciArianna Bellucci
Arianna Bellucci
Fibrillary aggregated α-synuclein (α-syn) deposition in Lewy bodies (LB) characterizes Parkinson's disease (PD) and is believed to trigger dopaminergic synaptic failure and a retrograde terminal-to-cell body neuronal degeneration. We described that the neuronal phosphoprotein synapsin III (Syn III) cooperates with α-syn to regulate dopamine (DA) release and can be found in the insoluble α-syn fibrils composing LB. Moreover, we showed that α-syn aggregates deposition, and the associated onset of synaptic deficits and neuronal degeneration occurring following adeno-associated viral vectors-mediated overexpression of human α-syn in the nigrostriatal system are hindered in Syn III knock out mice. This supports that Syn III facilitates α-syn aggregation.